A prediction model for short-term neurodevelopmental impairment in preterm infants with gestational age less than 32 weeks

被引:2
|
作者
Li, Yan [1 ]
Zhang, Zhihui [2 ]
Mo, Yan [3 ,4 ]
Wei, Qiufen [3 ,4 ]
Jing, Lianfang [3 ]
Li, Wei [3 ]
Luo, Mengmeng [5 ]
Zou, Linxia [3 ,4 ]
Liu, Xin [3 ]
Meng, Danhua [3 ]
Shi, Yuan [1 ]
机构
[1] Chongqing Med Univ, Natl Clin Res Ctr Child Hlth & Disorders, Dept Neonatol, Minist Educ,Key Lab Child Dev & Disorders,Children, Chongqing, Peoples R China
[2] Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Peoples R China
[3] Maternal & Child Hlth Hosp Guangxi Zhuang Autonomo, Neonatal Med Ctr, Nanning, Peoples R China
[4] Guangxi Clin Res Ctr Pediat Dis, Nanning, Peoples R China
[5] Univ Liverpool, Dept Biol Sci, Liverpool, England
关键词
gestational age less than 32 weeks; prematurity; neurodevelopmental impairment; support vector machine; principal component analysis;
D O I
10.3389/fnins.2023.1166800
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
IntroductionEarly identification and intervention of neurodevelopmental impairment in preterm infants may significantly improve their outcomes. This study aimed to build a prediction model for short-term neurodevelopmental impairment in preterm infants using machine learning method. MethodsPreterm infants with gestational age < 32 weeks who were hospitalized in The Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, and were followed-up to 18 months corrected age were included to build the prediction model. The training set and test set are divided according to 8:2 randomly by Microsoft Excel. We firstly established a logistic regression model to screen out the indicators that have a significant effect on predicting neurodevelopmental impairment. The normalized weights of each indicator were obtained by building a Support Vector Machine, in order to measure the importance of each predictor, then the dimension of the indicators was further reduced by principal component analysis methods. Both discrimination and calibration were assessed with a bootstrap of 505 resamples. ResultsIn total, 387 eligible cases were collected, 78 were randomly selected for external validation. Multivariate logistic regression demonstrated that gestational age(p = 0.0004), extrauterine growth restriction (p = 0.0367), vaginal delivery (p = 0.0009), and hyperbilirubinemia (0.0015) were more important to predict the occurrence of neurodevelopmental impairment in preterm infants. The Support Vector Machine had an area under the curve of 0.9800 on the training set. The results of the model were exported based on 10-fold cross-validation. In addition, the area under the curve on the test set is 0.70. The external validation proves the reliability of the prediction model. ConclusionA support vector machine based on perinatal factors was developed to predict the occurrence of neurodevelopmental impairment in preterm infants with gestational age < 32 weeks. The prediction model provides clinicians with an accurate and effective tool for the prevention and early intervention of neurodevelopmental impairment in this population.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] The impact of general anesthesia on the outcomes of preterm infants with gestational age less than 32 weeks delivered via cesarean section
    Wang, Lijun
    Liu, Chengxiao
    Wang, Xiaokang
    Zhu, Sha
    Zhang, Ligong
    Wang, Bo
    Yu, Yonghui
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [22] OBSTETRIC MANAGEMENT AND PERINATAL OUTCOME IN INFANTS LESS THAN 32 WEEKS GESTATIONAL-AGE
    AUDRA, P
    PUTET, G
    SALLE, B
    MELLIER, G
    DARGENT, D
    PEDIATRIE, 1988, 43 (03): : 257 - 261
  • [23] Reduced pulmonary oxygen diffusion at 36 weeks of postmenstrual age in small-for-gestational-age preterm infants of less than 32 weeks without bronchopulmonary dysplasia
    Correani, Alessio
    Lanciotti, Lucia
    Giorgetti, Chiara
    Palazzi, Maria Laura
    Monachesi, Chiara
    Antognoli, Luca
    Burattini, Ilaria
    Cogo, Paola
    Carnielli, Virgilio
    PEDIATRIC PULMONOLOGY, 2023, 58 (11) : 3054 - 3062
  • [24] Extrauterine growth restriction in preterm infants of gestational age ≤32 weeks
    Sakurai, Motoichiro
    Itabashi, Kazuo
    Sato, Yuko
    Hibino, Satoshi
    Mizuno, Katsumi
    PEDIATRICS INTERNATIONAL, 2008, 50 (01) : 70 - 75
  • [25] Differential Impact of Growth Variables on Neurodevelopmental Domains in ELBW Infants Less Than 26 Weeks Gestational Age
    DuRant, James M., III
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2015, 36 (02): : S18 - S18
  • [26] Pulmonary haemorrhage in infants with gestational age of less than 30 weeks
    M. P. De Carolis
    C. Romagnoli
    C. Cafforio
    F. Piersigilli
    P. Papacci
    G. Vento
    G. Tortorolo
    European Journal of Pediatrics, 1998, 157 : 1037 - 1038
  • [27] Pulmonary haemorrhage in infants with gestational age of less than 30 weeks
    De Carolis, RP
    Romagnoli, C
    Cafforio, C
    Piersigilli, F
    Papacci, P
    Vento, G
    Tortorolo, G
    EUROPEAN JOURNAL OF PEDIATRICS, 1998, 157 (12) : 1037 - 1038
  • [28] Early nasal continuous positive airway pressure failure prediction in preterm infants less than 32 weeks gestational age suffering from respiratory distress syndrome
    Dell'Orto, Valentina
    Nobile, Stefano
    Correani, Alessio
    Marchionni, Paolo
    Giretti, Ilaria
    Rondina, Clementina
    Burattini, Ilaria
    Palazzi, Maria L.
    Carnielli, Virgilio P.
    PEDIATRIC PULMONOLOGY, 2021, 56 (12) : 3879 - 3886
  • [29] Neurodevelopmental outcome of premature infants born at less than 33 weeks of gestational age, with no cerebral palsy at the age of five years
    Burguet, A
    Monnet, E
    Roth, P
    Hirn, F
    Vouaillat, C
    Lecourt-Ducret, M
    Fromentin, C
    Dornier, L
    Helias, J
    Choulot, MJ
    Allemand, H
    Maillet, R
    Menget, A
    ARCHIVES DE PEDIATRIE, 2000, 7 (04): : 357 - 368
  • [30] EXTENDED INTERVAL GENTAMICIN DOSING IN PRETERM INFANTS LESS THAN 35 WEEKS CORRECTED GESTATIONAL AGE.
    't Jong, G. W.
    McKitrick, J.
    Bewick, B.
    Ariano, R.
    Narvey, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S53 - S53